Bioiberica is a biotechnology company specialized in the research, development, production and distribution of biomolecules of high therapeutic value for the pharmaceutical, nutraceutical and food industries.


Vertically integrated, from the active ingredient to the finished product, at Bioiberica we control production from origin through to the end with total traceability. We have production units in several countries (Spain, USA, Poland, Italy and Brazil), where we select and control the highest quality raw materials with strict quality and biological controls through environmentally harmless processes.


In our centre of production excellence in Palafolls (Barcelona) is where the final purification processes for the different active ingredients are carried out and the raw material is converted into a product of the maximum purity, always manufactured following pharmaceutical standards and according to Good Manufacturing Practices.

Bioiberica researches, develops, manufactures and markets the following active pharmaceutical ingredients:


Bioiberica obtains Chondroitin Sulfate from different sources of animal cartilage. The use of the highest quality raw materials, together with its proces­sing method, guarantee chondroitin sulfate 100% assay every time, minimizing the presence of impurities and overcoming the quality requirements of the most important Pharmacopoeias worldwide.

It offers different types of chondroitin sulfate, with certifications and documents to support its quality (DMF,CEP)

Bioiberica’s Chondroitin Sulfate is the substance of chemical reference in the european and the united states pharmacopoeias.


Bioiberica’s glucosamine is produced by hydrolysis of crustacean shells, and Bioiberica makes it available in the form of any of its salts. Just like all Bioiberica products, glucosamine is obtained from the highest quality raw material and follows strict quality and tra­ceability controls, which ensures the maximum purity and guaran­tees the final product’s efficacy and safety.

Bioiberica offers different types of glucosamine, with certifications and documents to support its quality (DMF).

Bioiberica’s glucosamine is registered as a drug for the symptomatic treatment of osteoarthritis in

over 20 countries


Bioiberica produces great purity sodium hyaluronate from cockscomb through a specific process comprising several steps of digestion and purification to make it available in diffe­rent molecular weights/viscosities, depending on customers’ requirements, and suitable for any commercial application.

Bioiberica offers different types of sodium hyaluronate from extraction, with certifications and documents to support its quality

Bioiberica manufactures its injectable sodium hyaluronate following pharmaceutical standards in a dedicated state-of-the-art facility, which ensures the highest quality and safety product.